Spectral Domain Optical Coherence Tomography for Glaucoma Diagnostics

Spectral Domain Optical Coherence Tomography for Glaucoma Diagnostics - SDOCT & Glaucoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39104

Enrollment

600

Registered

2008-05-07

Start date

2008-09-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma ocular hypertension

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All 3 groups: Age >= 18 years and

Exclusion criteria

Exclusion criteria: All 3 groups: Ophthalmic: BCVA > 0.3 (LogMAR). Refractive error ouside -10.0 to +5.0 D range. Cataract surgery in previous 12 months. Previous refractive or vitreoretinal surgery. Evidence of diabetic retinopathy, diabetic macular edema, or other vitreo-retinal disease. Previous keratoplastic surgery. Systemic: Diabetes, leukemia, AIDS, uncontrolled systemic hypertension, multiple sclerosis or life threatening disease.;Group 1: Glaucoma in either eye. IOP >= 22 mm Hg in either eye. Untreated occludable angle with iridolenticular contact or evidence of iridolenticular contact or peripheral anterior synechia. Presence of disc hemorrhage.;Group 2: Secondary glaucomas except pigmentary. Evidence of SAP VF abnormality consistent with other disease. ;Group 3: Evidence of SAP VF abnormality consistent with other disease.

Design outcomes

Primary

Measure	Time frame
Structural measurements of optic nerve head and surrounding retinal nerve fibre layer, functional measurements of visual fields, diagnostic accuracy, measurement reproducibility, progression rates.	—

Secondary

Measure	Time frame
See protocol.	—

Countries

Netherlands

Outcome results